Us Congress House Bill HB1396

Us Congress 2025-2026 Regular Session

• Introduced: 2/14/25
• Refer: 2/14/25

Caption

To amend the Internal Revenue Code of 1986 to establish the generic drugs and biosimilars production credit, and for other purposes.